Skip to content

Clinical trials

Terminated Gastrointestinal Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Status: Terminated Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20062
20072
20082
20091
20101
20111
20121
20131
20143
20151
20171
20185
20192
20202
20213
20224
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
M.D. Anderson Cancer Center2
Stanford University2
University of Utah2
Anthos Therapeutics, Inc.1
BioMed Valley Discoveries, Inc1
Bolt Biotherapeutics, Inc.1
Brian Anderson, MD1
Bristol-Myers Squibb1
Columbia University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms38
Neoplasms10
Colorectal Neoplasms9
Breast Neoplasms8
Stomach Neoplasms7
Colonic Neoplasms6
Digestive System Neoplasms6
Melanoma6
Pancreatic Neoplasms6
Digestive System Diseases5

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.